Intangibles |
6 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||||
| Intangibles | 4. Intangibles As a result of the Acquisition of Theriva S.L., the Company has an intangible asset, in-process research and development (“IPR&D”). The IPR&D is deemed to have indefinite lives and therefore not amortized. The following table provides the Company’s in-process R&D as of June 30, 2026.
There were no impairment charges recorded during the three and six months ended June 30, 2026 and 2025. |
||||||||||||||||||||||||